Biological drugs for the treatment of children with chronic spontaneous urticaria

Sadeleştirilmiş öğe sayfası
dc.contributor.authorPodder, Indrashis
dc.contributor.authorSalman, Andac
dc.contributor.authorAsero, Riccardo
dc.contributor.authorCaballero, Maria Teresa
dc.contributor.authorCaffarelli, Carlo
dc.contributor.authorDe las Vecillas, Leticia
dc.contributor.authorGimenez\\-Arnau, Ana Maria
dc.contributor.authorGiovannini, Mattia
dc.contributor.authorKocatuerk, Emek
dc.contributor.authorKolkhir, Pavel
dc.contributor.authorManti, Sara
dc.contributor.authorCascales, Tatiana Navarro
dc.contributor.authorMaurer, Marcus
dc.date.accessioned2025-10-16T15:12:33Z
dc.date.issued2024
dc.identifier.doi10.1080/1744666X.2024.2388689
dc.identifier.otherWOS:001357571200001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5494
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceEXPERT REVIEW OF CLINICAL IMMUNOLOGY
dc.subjectChronic spontaneous urticaria
dc.subjectchildren
dc.subjectomalizumab
dc.subjectbiologics
dc.subjectwheals
dc.subjectangioedema
dc.subjectpediatrics
dc.titleBiological drugs for the treatment of children with chronic spontaneous urticaria
dc.typeReview

Dosyalar

Koleksiyonlar

WOS